[1]郭铁,雷励△,程平荣,等.补肾活血片治疗血管性痴呆60例[J].西部中医药,2019,32(06):75-77.
 GUO Tie,LEI Li,CHENG Pingrong,et al.Treatment for 60 Cases of Vascular Dementia by Kidney-invigorating Blood-activating Tablets[J].Western Journal of Traditional Chinese Medicine,2019,32(06):75-77.
点击复制

补肾活血片治疗血管性痴呆60例
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
32
期数:
2019年06期
页码:
75-77
栏目:
出版日期:
2019-06-15

文章信息/Info

Title:
Treatment for 60 Cases of Vascular Dementia by Kidney-invigorating Blood-activating Tablets
文章编号:
1004-6852(2019)06-0075-03
作者:
郭铁雷励△程平荣陈焱彬
重庆市北碚区中医院脑病一科,重庆 400700
Author(s):
GUO Tie, LEI Li△, CHENG Pingrong, CHEN Yanbin
The First Department of Encephalopathy, Beibei TCM Hospital, Chongqing 400700, China
关键词:
血管性痴呆补肾活血片认知功能生活质量
Keywords:
vascular dementia kidney-invigorating blood-activating tablets cognitive function quality of life
分类号:
R255.2
文献标志码:
B
摘要:
目的:观察补肾活血片治疗血管性痴呆的临床疗效。方法:将120例患者随机分为观察组和对照组,每组60例。2组均给予血管性痴呆患者常规疗法治疗。对照组同时服用胞磷胆碱片,0.2 g/次,3次/d;观察组同时服用补肾活血片,4片/次,3次/d,比较临床疗效,并利用长谷川痴呆量表(HDS)、日常生活能力量表(ADL)和简易精神状况评价量表(MMSE)比较2组患者的HDS、ADL和MMSE评分。结果:总有效率观察组为93.33%,对照组为73.33%,2组比较差异有统计学意义(P<0.05)。不良反应发生率观察组为3.33%,对照组为8.33%,2组比较差异有统计学意义(P<0.05)。HDS及ADL评分治疗前后2组组内比较,差异有统计学意义(P<0.05);治疗后组间比较差异也有统计学意义(P<0.05)。MMSE评分治疗后2组比较,差异有统计学意义(P<0.05)。结论:补肾活血片可有效提高血管性痴呆患者的临床治疗效果,改善患者HDS、ADL和MMSE评分。
Abstract:
Objective: To observe clinical effects of kidney-invigorating blood-activating tablets in treating vascular dementia (VD). Methods: All 120 patients were allocated to two groups, both groups accepted conventional therapy of VD, the control group took citicoline tablets simultaneously, three times each day, 0.2 g each time; the observation group were given kidney-invigorating blood-activating tablets four pills each time, three times each day. To compare clinical effects, HDS scores, ADL and MMSE scores between both groups. Results: Total effective rate of the observation group was 93.33%, higher than 73.33% of the control group, and the difference showed statistical meaning (P<0.05). The incidence of adverse reaction in the observation group was 3.33%, lower than 8.33% of the control group, and the difference was statistically significant (P<0.05). The difference was statistically significant in the comparisons of HDS and ADL scores within two groups before and after treating (P<0.05); the difference could be found between both groups after treating (P<0.05). The difference was statistically significant in MMSE scores between both groups after treating (P<0.05). Conclusion: Kidney-invigorating blood-activating tablets could raise therapeutic effects of VD patients, improve HDS, ADL and MMSE scores.

相似文献/References:

[1]高晓兰,朱增强,陈彦文,等.当归补血汤加味对血管性痴呆大鼠的脑保护作用研究[J].西部中医药,2013,26(04):22.
 GAO Xiaolan,ZHU Zengqiang,CHEN Yanwen,et al.Study on Modified DangGui BuXueTang to Cerebral Protection of Rats with Vascular Dementia[J].Western Journal of Traditional Chinese Medicine,2013,26(06):22.
[2]李伟伟,王鸣池,于盼盼,等.奥拉西坦联合三七通舒治疗血管性痴呆的临床疗效观察[J].西部中医药,2013,26(02):81.
 LI Weiwei,WANG Mingchi,YU Panpan,et al.Observation on Clinical Effects of Oxiracetam Capsule and SanQi TongShu Capsule in Treating Vascular Dementia[J].Western Journal of Traditional Chinese Medicine,2013,26(06):81.
[3]王保平,张圆,陈怡名,等.龙首参葛丸对血管性痴呆大鼠海马CA1区组织结构变化的影响[J].西部中医药,2019,32(06):6.
 WANG Baoping,ZHANG Yuan,CHEN Yiming,et al.Impact of LongShou ShenGe Pills on the Structural Changes of the Tissue in Hippocampal CAI Region of the Rat with Vascular Dementia[J].Western Journal of Traditional Chinese Medicine,2019,32(06):6.
[4]张慧,张婷,陈锐,等.醒脑方对血管性痴呆大鼠脑组织学习记忆能力的保护作用[J].西部中医药,2020,33(07):20.[doi:10.12174/j.issn.1004-6852.2020.07.05]
 ZHANG Hui,ZHANG Ting,et al.Protective Effects of Xingnao Prescription on Learning and Memory Ability of Brain Tissue in VD Rats[J].Western Journal of Traditional Chinese Medicine,2020,33(06):20.[doi:10.12174/j.issn.1004-6852.2020.07.05]
[5]陈业文,陈炜,吴林,等.基于肠道微生物探讨从脾胃论治血管性痴呆[J].西部中医药,2021,34(04):145.[doi:10.12174/j.issn.2096-9600.2021.04.36]
 CHEN Yewen,CHEN Wei,WU Lin,et al.Discussion on Treating Vascular Dementia from Spleen and Stomach Based on Intestinal Microorganism[J].Western Journal of Traditional Chinese Medicine,2021,34(06):145.[doi:10.12174/j.issn.2096-9600.2021.04.36]
[6]孟胜喜,付剑亮,霍清萍,等.恒清Ⅰ号方联合盐酸多奈哌齐对血管性痴呆患者的作用及其机制研究[J].西部中医药,2021,34(01):1.[doi:10.12174/j.issn.2096-9600.2021.01.01]
 MENG Shengxi,FU Jianliang,HUO Qingping,et al.Study on the Effects of Hengqing Prescription No.1 and Donepezil Hydrochloride on Vascular Dementia and Its Mechanism[J].Western Journal of Traditional Chinese Medicine,2021,34(06):1.[doi:10.12174/j.issn.2096-9600.2021.01.01]
[7]陈静,陈炜,唐秀松,等.基于网络药理学探讨丹参治疗血管性痴呆的作用机制[J].西部中医药,2022,35(11):22.[doi:10.12174/j.issn.2096-9600.2022.11.05]
 CHEN Jing,CHEN Wei,TANG Xiusong,et al.Discussion on the Mechanism of Danshen in the Treatment of Vascular Dementia Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(06):22.[doi:10.12174/j.issn.2096-9600.2022.11.05]
[8]崔友祥,刘国华,霍飞飞,等.芪参还五胶囊对血管性痴呆痰瘀互结型患者认知功能及血清标志物的影响[J].西部中医药,2023,36(03):119.[doi:10.12174/j.issn.2096-9600.2023.03.23]
 CUI Youxiang,LIU Guohua,HUO Feifei,et al.Influence of Qishen Huanwu Capsules on Cognitive Function and Serum Marker in Patients with Vascular Dementia of Phlegm Blending with Stasis Pattern[J].Western Journal of Traditional Chinese Medicine,2023,36(06):119.[doi:10.12174/j.issn.2096-9600.2023.03.23]
[9]常慧,史宏硕,司国民.司国民教授基于气、血、水、毒理论辨治血管性痴呆[J].西部中医药,2024,37(02):36.[doi:10.12174/j.issn.2096-9600.2024.02.08]
 CHANG Hui,SHI Hongshuo,SI Guomin.Professor Si Guomin′s Differentiation and Treatment of Vascular Dementia on the Foundation of Qi, Blood, Water and Toxin Theory[J].Western Journal of Traditional Chinese Medicine,2024,37(06):36.[doi:10.12174/j.issn.2096-9600.2024.02.08]

备注/Memo

备注/Memo:
收稿日期:2018-10-21*基金项目:重庆市卫生局课题资助项目(编号2012-2-51)。作者简介:郭铁(1980—),男,副主任医师。研究方向:中医脑病的临床诊治。△通讯作者:雷励(1970—),女,主任医师。研究方向:中医脑病的临床诊治。
更新日期/Last Update: 2019-06-15